Integrated digital health solutions company Recuro Health has announced the closing of a $47 million (£37.8 million) Series B round investment.
The Series B syndicate includes both new and existing investors, including ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital and others.
Recuro will use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioural Health Solutions that are tailored to fit the healthcare needs of any population.
The Digital Medical Home care model integrates advanced science, data, at-home diagnostics and targeted genomics to better inform integrated care.
Recuro Health founder and CEO, Michael Gorton, said:
“The continued support of our investors is a clear sign of their confidence in our mission.
“We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs.
“In this next phase of our Company growth and expansion, we are committed to building upon the success of our Digital Medical Home and continuing to advance the next generation of digital care services.”
Recuro’s Digital Medical Home enables connectivity to virtual care, including primary and urgent care, behavioural health, at-home lab testing, genomics testing, as well as a suite of supplemental offering spanning pharmacy, care management and care navigation in one platform
Robert Nelsen, co-founder and managing director, ARCH Venture Partners, added:
“Recuro is proving to be the best of breed in the intersection of science, diagnostics and digital health.
“This nimble organisation has the ability to quickly respond to market changes, scale its tech-enabled services and close gaps in care that improve population health.
“We see significant opportunities for exceptional growth and continued success.”
